Clinical Trial

Skin-to-Skin Contact and Lavender Aromatherapy After Elective Cesarean: Effects on Cortisol and Early Breastfeeding

Study acronym: LAVENDER-SSC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This single-center randomized controlled clinical trial will evaluate the effects of structured early postpartum mother-infant skin-to-skin contact, with or without maternal lavender aromatherapy, after elective cesarean section on maternal stress biomarkers and early breastfeeding outcomes. The study will enroll 150 term pregnant women scheduled for elective cesarean section under spinal anesthesia at Ataturk University Research Hospital. Participants will be randomized into three groups: routine postoperative care, structured skin-to-skin contact, and structured skin-to-skin contact combined with inhalational lavender aromatherapy. The primary outcome is the change in maternal salivary cortisol level from immediately after birth to 60 minutes postpartum. Secondary outcomes include maternal salivary IgA levels, state anxiety scores, postoperative pain and nausea, time to first analgesic requirement, early breastfeeding initiation and success, LATCH scores, neonatal axillary temperature, cumulative duration and continuity of skin-to-skin contact, maternal satisfaction, and the need for mother-infant separation within the first 2 hours postpartum.
Trial Details
NCT Number NCT07612059
Lead Sponsor Ataturk University
Conditions Breastfeeding, Cesarean Section, Postpartum Period, Maternal Stress
Enrollment 150 participants
Start Date 2026-06-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-28